Study, year | MS/DS (n) | Symptoms onset-to-thrombolysis, min (MS/DS)* | Symptoms onset-to-puncture, min (MS/DS)* | Symptoms onset-to-successful reperfusion, min (MS/DS)* |
Saver et al10 2015 | 67/31 | NA | 179 (147–238)/275 (245–334) | NA |
Park et al11 2016 | 77/28 | NA | 219±56/300±63 | NA |
Prothmann et al12 2017 | 38/53 | NA | 137/233 | 180 (112–386)/289 (172– 469)† |
Weber et al13 2016 | 300/343 | 92±114/115±116 | 150 (34–913)/233 (60–1260)† | 245 (69–1022)/292 (91–1376)† |
Rinaldo et al14 2017 | 62/78 | NA | NA | 277±173/420±220 |
Gerschenfeld et al15 2017 | 59/100 | 135 (114–155)/150 (120–190) | 189 (163–212)/248 (220–291) | 240 (202–285)/297 (255–357) |
Froehler et al17 2017 | 539/445 | 110/98 | 158/274 | 202 (160–265)/311.5 (255–356) |
Weisenburger-Lile et al16 2018 | 286/602 | 131 (110–161)/150 (120–180) | 171 (142–208)/260 (222–300) | 218 (181–260)/315 (266– 375) |
Successful reperfusion was defined as TICI or mTICI ≥2b at the end of thrombectomy.
↵*Mean±SD or median (IQR) reported; †range.
DS, drip and ship; MS, mothership; mTICI; modified Thrombolysis In Cerebral Infarction.